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Background. The dialysis dose, Kt/V, and Solute Removal Index
(SRI) have been proposed as tools to measure and compare
adequacy of different renal replacement therapies in adults. The
aim of our study was to elucidate whether the Kt/V and SRI could
be appropriate parameters to compare different treatments and
define adequacy targets in children.
Methods. Twenty-two pediatric chronic dialysis patients (2 to 17
years) were prospectively studied. Six patients were on continuous
ambulatory peritoneal dialysis (CAPD), 7 patients were on auto-
matic nightly peritoneal dialysis (ANPD), and 9 were on hemo-
dialysis (HD). Patients had no peritonitis and were not hospital-
ized during the previous two months and, as proved by growth and
subjective well being, were in steady state condition at the
initiation of the protocol. As a consequence, the treatment
delivered was assumed to be adequate and the prospective
analysis was carried out within one month. Urea levels in dialy-
sate, plasma and urine were measured to determine urea kinetics
and measure adequacy parameters.
Results. Instantaneous urea clearance was much higher when
hemodialysis was used (124.67 6 32.04 ml/min) compared to
CAPD (2.79 6 0.29 ml/min) and ANPD (6.60 6 1.42 ml/min), as
expected. The Urea dialytic clearance per week was greater in HD
(67320 6 17299 ml) than in CAPD(28144 6 2895 ml) and ANPD
(29910 6 4234 ml). Residual renal function contributed to the
overall weekly clearance by 47% in CAPD, while it was only by
19% in HD and 26% in ANPD. The overall weekly clearance was
therefore 79,842 ml/week in HD, 53,340 ml/week in CAPD and
41,012 ml/week in ANPD. Weekly dialytic Kt/V results were much
higher in HD (3.75) than in CAPD (1.78) and ANPD (2.37). To
these values, the renal Kt/V was added, reaching the values of
overall (dialytic 1 renal) weekly Kt/V of 4.53 in HD, 3.41 in
CAPD and 3.41 in ANPD. Although higher Kt/V values were
observed in HD, when the SRI % was considered, HD appeared
to be less efficient compared with the other two techniques. Since
postdialytic rebound in HD patients averaged 22.5%, we may
speculate that hemodialysis in children is less efficient than
continuous or daily peritoneal dialysis because of a remarkable
cardipulmonary recirculation and solute sequestration.
Conclusion. In the global evaluation, dialysis SRI% appears to
be more reliable as an index of adequacy compared to Kt/V in
children. At least an integration between the two indices is
strongly recommended.
The definition of adequacy in patients undergoing differ-
ent dialysis treatments is still a matter of controversy [1],
and the assessment of nutritional status in such patients is
a further object of discussion. The use of urea as a marker
molecule for dialysis adequacy has been extensively studied
[2, 3]. In a general sense, treatment is considered adequate
when blood urea nitrogen (BUN) is maintained within
acceptable ranges in presence of a sufficient dietary protein
intake.
The American Cooperative Dialysis Study and its mech-
anistic analysis have focused attention on an index (Kt/V)
based on the fractional clearance of urea versus total body
water (TBW). In this study, a weekly urea Kt/V greater
than 3 was the minimum efficiency required to obtain low
morbidity rate and reduced the probability of treatment
failure in patients undergoing hemodialysis (HD) [4, 5]
Nolph and Keshaviah have recently proposed that a
weekly Kt/V between 1.7 and 2.0 should be obtained in
continuous ambulatory peritoneal dialysis (CAPD) [6]. A
weekly Kt/V of 2.2 has been suggested as a minimum dose
for patients undergoing automated nightly peritoneal dial-
ysis (ANPD). Different values of Kt/V are therefore ade-
quate for different treatments due to the different urea
kinetics in the various techniques [7].
Nevertheless, while the Kt/V index has been validated in
adults and target values have been defined for different
techniques, such validation is still needed for pediatric
patients. Clinical studies are required to elucidate whether
urea kinetics and Kt/V are appropriate tools for the
evaluation of treatment adequacy in children. Further-
more, target values of efficiency for various dialysis treat-
ments should be defined to permit comparison among
different renal replacement therapies.
Recently, Ronco et al have proposed using solute re-
moval as an additional parameter to better define differ-
ences in Kt/V among treatments [8]. As a further step,
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Keshaviah [9] and Ronco et al [10] have proposed using the
Solute Removal Index (SRI) as a unified basis for compar-
ing disparate therapies. The SRI is also based on solute
removal, but it normalizes removal by the solute content of
the body at the beginning of the treatment or at the
beginning of the week. In this view, SRI should allow the
comparison of intermittent and continuous therapies that
could not be compared before because of the different
Kt/V scalings.
To elucidate some of these controversial points, and to
explore whether the Solute Removal Index would be an
appropriate parameter to compare different treatments in
children, we prospectively studied a pediatric population
undergoing hemodialysis and peritoneal dialysis. Patients
had no peritonitis and were not hospitalized during the two
months before the study commenced and were in a steady
state condition at the initiation of the protocol. As a
consequence, the treatment delivered was assumed to be
adequate.
METHODS
Twenty-two pediatric dialysis patients were included in
the study: 6 patients were on continuous ambulatory peri-
toneal dialysis (CAPD; defined as 4 exchanges per day, 7
days/week, average infusion volume/exchange 5 37.5 ml/
kg), 7 patients were on automatic nightly peritoneal dialysis
(ANPD; an average infusion 400 ml/kg per night, 7 days/
week), and 9 were on hemodialysis (HD; 180 min/session 3
times weekly). The inclusion criteria were patient age
between 2 and 17 years, and treatment with renal replace-
ment therapy for more than six months. Criteria for
treatment adequacy included analysis of growth (weight,
length and head circumference), active social life, clinical
assessment, school performance (scoring of 7/10 or above
in the elementary or middle school), family interaction,
subjective patient well being and appetite, and absence of
peritonitis episodes or hospitalization in the two months
before the study.
The characteristics of the groups are summarized in
Table 1. Residual renal function was evaluated by daily
collection of urine and calculated as the average between
creatinine and urea clearances. A complete dietary survey
was carried out by a dietician over a period of one week in
all patients. During one day of this week, CAPD patients
were asked to collect the whole amount of spent dialysate
drained from the peritoneal cavity in 24 hours and to
collect the total urine output. Dialysate bags and urine
output were measured and a sample of fluid was drawn
from each bag and from the urine container. A blood
sample was drawn in the morning following the 24 hour
collection. In all samples, urea nitrogen, creatinine, albu-
min and total protein concentration were measured. Total
solute removal was calculated from the sum of the products
(concentration 3 volume) in each bag and in urine. Instan-
taneous solute clearances (K) were measured from the
ratio between removal rate and average serum concentra-
tion. Peritoneal (Kp 5 Kperitoneal) and urinary (Kr 5 Krenal)
clearances were added to obtain total instantaneous clear-
ance (Kpr 5 Kperitoneal 1 renal).
The same procedure was undertaken for ANPD patients
analyzing the whole amount of spent dialysate and the
pre-post-dialysis blood concentrations.
For hemodialysis patients (HD) the same procedure was
carried out by collecting the whole amount of spent dialy-
sate and pre-post-dialysis blood samples. A blood sample
was also collected 30 minutes after the session had ended,
to measure equilibrated Kt/V and urea rebound value.
Weekly clearances were calculated in all patients from the
total collection of spent dialysate. Kt/V, urea distribution
volume and urea generation rates were measured in HD by
a variable volume kinetic model using a computerized
program [11]. In a limited number of cases a bioimpedance
measurement was carried out to obtain further information
on total body water.
Weekly Kt/V including residual renal function was cal-
culated in all patients as suggested by Gotch and Sargent
[5] and compared per Calzavara et al [12]. For peritoneal
dialysis, wKprt/V is defined as weekly K(peritoneal 1 renal) t/V,
and for hemodialysis wKdrt/V is weekly K(dialytic 1 renal) t/V.
The SRI was calculated for all patients as suggested by
Keshaviah [9] and Ronco et al [10]. This index has been
suggested to be a more reliable method to compare dispar-
ate therapies, since it considers the amount of solute
removed and normalizes it by the amount of solute present
in the body at the beginning of treatment.
The protein catabolic rate (PCR) was calculated from
direct dialysate quantification utilizing the formula,
PCR 5 ~UNex 1 nonUNex! 3 6.25
1 Pr Loss ~urine 1 dialysate!
where UNex and nonUNex are the daily excretion of urea
and non-urea nitrogen (urine 1 dialysate 1 obligatory
losses in the stools and breath), respectively, and Pr Loss is
dialysate loss.
It is still controversial whether PCR in children can be
considered a real marker of protein nutrition. In fact, the
Table 1. Characteristics of the population
HD CAPD ANPD
Number of patients 9 (5M–4F) 6 (4M–2F) 7 (5M–2F)
Age years 12.16 6 3.64 8.61 6 3.49 10.97 6 1.76
Weight kg 28.01 6 10.7 26.37 6 3.0 21.94 6 5.9
Serum albumin g/dl 4.11 6 0.15 4.28 6 0.1 4.18 6 0.14
Hematocrit % 32.7 6 1.5 31.4 6 2.5 32.6 6 2.6
Surface area m2 1.02 6 0.25 0.98 6 0.07 0.81 6 0.18
Dialytic age months 12.67 6 13.02 7.17 6 5.64 27.14 6 18.92
Residual renal function
ml/min
1.24 6 1.79 2.50 6 1.57 1.10 6 1.72
Abbreviations are: HD, hemodialysis; CAPD, continuous ambulatory
peritoneal dialysis; ANPD, automatic nightly peritoneal dialysis.
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correspondence between PCR and daily protein intake is
only effective when the patient is in a steady state metab-
olism. Since some patients are undergoing growth hormone
therapy, the presence of a certain degree of anabolism
could be hypothesized. Under such circumstances PCR
should be probably substituted with the term, protein
equivalent of the urea nitrogen appearance (PNA) rate.
Furthermore, PCR is generally normalized by the ideal
body weight utilizing the formula V/0.58, once the sex,
height and weight of the patient are given. This represents
the ideal body weight by which the daily protein intake
should be prescribed. It is not clear whether such an
assumption can be made in the young.
RESULTS
In hemodialysis patients the average volume of ultrafil-
tration per week was 4149 6 755 ml while the urine output
was 2590 6 2479 ml/week. Body weights remained un-
changed during the observation period of one week.
In CAPD the average fluid withdrawal obtained via the
peritoneal route was 2811 6 1715 ml/week, with a wide
variability among patients. The lower ultrafiltration rates
were observed in patients with the higher level of residual
renal function. This is probably due to the fact that these
patients are closer than others to the real dry body wt.
Urine output averaged 3920 6 1666 ml/week and the body
wt remained unchanged during the study period.
In ANPD patients the average volume of ultrafiltration
per week was 4382 6 1496 ml, while the urine output was
1750 6 2184 ml/week. Body weight remained unchanged
during the observation period of one week. Treatment
data, urea kinetic parameters and adequacy measurements
are reported in Table 2, and the nutritional parameters are
reported in Table 3.
Instantaneous urea clearance was much higher in hemo-
dialysis (124.67 6 32.04 ml/min) compared to CAPD
(2.79 6 0.29 ml/min) and ANPD (6.60 6 1.42 ml/min)
patients. The dialytic clearance per week was greater in HD
than in CAPD and ANPD. This is not surprising if one
considers that the concentration profile of BUN has an
exponential decrease during each session of HD, while in
ANPD and above all in CAPD the BUN levels are fairly
stable over time.
Urea clearance relevant to residual renal function con-
tributed to the overall weekly clearance by 47% in CAPD,
while it was only by 19% in HD and 26% in ANPD. The
overall weekly clearance therefore resulted in 79,842 ml/
week in HD, 53,340 ml/week in CAPD and 41,012 ml/week
in ANPD.
Weekly dialytic Kt/V results were much higher in HD
(3.75) than in CAPD (1.78) and ANPD (2.37). These values
were all above the recommended targets for adequate
treatment. To these values, the renal Kt/V should be added,
reaching the values of overall (dialytic 1 renal) weekly
Kt/V of 4.53 in HD, 3.41 in CAPD and 3.41 in ANPD.
Although higher Kt/V values were observed in HD, when
the SRI % is considered, HD appeared to have the lowest
efficiency compared to the other two techniques. This can
be explained by the slightly higher body weights of the
patients on HD, but above all by the higher peak concen-
trations of BUN. These values are clearly reported in Table
3 where time averaged concentrations (TAC) of BUN are
also reported. The highest removal of urea achieved in
patients undergoing HD was not only due to the efficiency
Table 2. Dialytic parameters in the treated groups
HD CAPD ANPD
Treatment time min 540 6 30 10080 4662 6 1008
Frequency 3/week Continuous daily
Dialytic clearance ml/week 67320 6 17299 28114 6 2895 29910 6 4234
Residual renal clearance ml/week 12522 6 18.043 25200 6 15825 11102 6 17300
Overall urea clearance ml/week 79842 6 35342 53340 6 18720 41012 6 21534
Dialytic urea removal mg/week 39980 6 17909 19063 6 21539 22335 6 4752
Renal urea removal mg/week 4991 6 8211 7672 6 3619 3486 6 4914
Weekly urea Kt/V dialysis only 3.75 6 1.06 1.78 6 0.08 2.37 6 0.48
Weekly urea Kt/V dialysis 1 renal 4.53 6 1.93 3.41 6 1.08 3.41 6 2.07
Dialytic Solute Removal Index 1.51 6 0.36 1.78 6 0.08 2.08 6 0.36
Weekly Kt/SA dialysis only 59471 6 8648 28795 6 1786 37859 6 7058
Weekly Kt/SA dialysis 1 renal 72092 6 20293 54840 6 6332 52770 6 24707
Abbreviations are in Table 1. SA is surface area.
Table 3. Metabolic parameters in the treated population
HD CAPD ANPD
Urea generation rate
mg/24 h/kg
0.26 6 0.15 0.18 6 0.04 0.21 6 0.04
Urea generation
mg/week
45260 6 9406 32458 6 4217 32019 6 7485
Dietary protein intake
g/kg/day
2.0 6 0.71 1.5 6 0.1 1.5 6 0.53
Protein catabolic rate
g/kg/day
1.62 6 0.94 1.12 6 0.24 1.34 6 0.27
Urea distribution volume
ml
17246 6 6658 15820 6 1779 13161 6 3570
Peak BUN 124.0 6 28.1 68.5 6 13.6 80.2 6 13.4
TAC BUN 93.3 6 14.2 68.5 6 13.6 75.6 6 12.1
Abbreviations are: BUN, blood urea nitrogen; TAC, time averaged
concentration; HD, hemodialysis; CAPD, continuous ambulatory perito-
neal dialysis; ANPD, automatic nightly peritoneal dialysis.
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of the therapy, but also to the higher concentration of BUN
in these patients. Since the postdialytic rebound in HD
patients averaged 22.5%, we may speculate that hemodial-
ysis in children is always less efficient than continuous or
daily peritoneal dialysis because of a remarkable cardipul-
monary recirculation and solute sequestration in poorly
perfused districts of the body. This phenomenon, already
known in the adult, is probably even more evident in
children, where the discrepancy between dialyzer mass
transfer coefficient and intracorporeal intercompartimental
mass transfer coefficient is probably greater. The small
number of patients in each group did not permit an
evaluation of the correlation between Kt/V and the dietary
protein intake (DPI) or protein catabolic rate (PCR). In
Table 3, however, the nutritional parameters demonstrate
that a greater degree of catabolism is present in the HD
group. In all of the groups PCR was always lower than DPI,
demonstrating that all patients were in a clinical condition
of anabolism. This is important and suggests that PCR
alone cannot be critically used to describe protein intake in
patients who are not under metabolic steady state condi-
tions.
The comparison of total body water measured by urea
kinetics and by bioelectric impedance did not demonstrate
significant differences, the average error between the two
methods being lower than 8%.
DISCUSSION
Today’s approach to chronic renal replacement therapy
is seen as full integration among different dialysis tech-
niques [11]. In this approach, patients are moving from one
technique to another, depending on clinical needs and
technical requirements. Different dialysis techniques, how-
ever, have different characteristics and operate under dif-
ferent conditions. The frequency of dialysis sessions and
the kinetics of solute removal during treatment make the
analysis of the treatment efficiency extremely difficult and
renders the comparison among different therapies a com-
plicated task [12]. Assessment of dialysis adequacy in
children is even more complicated, since there is a wide
variability of patient size in pediatic populations [13].
The present study has confirmed that urea can be used as
a marker molecule for the assessment of treatment ade-
quacy in children. The target Kt/Vs recommended for HD,
ANPD and CAPD were achieved in the present popula-
tion, demonstrating that clinical well being and the meta-
bolic indices were coupled and the treatment delivered was
adequate in all groups. The values of Kt/V, however, were
remarkably different among treatments and even more
different if the residual renal function was included in the
calculation. This demonstrates that Kt/V has different
scaling in different treatments, and it cannot be used as a
common basis for comparing disparate therapies [14].
For this purpose, we have utilized the recently described
Solute Removal Index (SRI) together with a complete
evaluation of the urea mass balance in the groups studied.
Kt/V is an index that reflects the fractional relationship
between the liters of clearance achieved in a given treat-
ment and the liters of total body water (that is, urea
distribution space). This index has major drawbacks when
the value of K (clearance) is very high and the value of t
(time) is very small. In fact, under these circumstances
(typically high efficiency intermittent hemodialysis) the
mass transfer coefficient achieved in the extracorporeal
system (dialyzer) is much higher than the mass transfer
coefficient between body compartments and the blood of
the patient. Therefore, liters of clearance do not represent
a parameter that can be correlated with solute removal.
This correlation can only be made when the BUN level is in
steady state and the treatment is performed continuously
24 hours a day. For this reason, Ronco et al have proposed
to also analyze the capacity of removal for different solutes
offered by each technique. Removal, however, can only be
used for comparison when the blood solute concentration
at the beginning of the treatment and the total body water
of the patients are comparable. To avoid this problem, the
Solute Removal Index takes into consideration all these
parameters by normalizing the amount removed by the
solute content in the body at the beginning of the treat-
ment.
For CAPD, the SRI is defined as below.
SRI 5
Removal
Body content 5
Vd 3 Cd 1 Vu 3 Cu
Vb 3 Cb
where V and C are volume and concentration, respectively,
and subscripts d, u and b refer to dialysate, urine and body
water, respectively. This value can be multiplied by 7 to
achieve weekly values. As suggested by Keshaviah [9] and
Ronco et al [10], the dialytic SRI was equal to Kt/V in
CAPD, while it was very different from Kt/V in ANPD and
even more different in HD. In HD weekly SRI can be
calculated as follows:
SRI 5
~Vd1 3 Cd1!
~Vb1 3 Cb1!
1
~Vd2 3 Cd2!
~Vb2 3 Cb2!
1
~Vd3 3 Cd3!
~Vb3 3 Cb3!
1
Vu 3 Cu
Vb 3 Cb
where V and C are volume and concentration, respectively,
and subscripts d, u and b refer to dialysate, urine and body
water, respectively. The numbers 1, 2 and 3 refer to the HD
session of the week.
SRI becomes very different when residual renal function
is added to the calculation. In these conditions, the effi-
ciency of CAPD results were much higher in comparison
with other treatments, due to its intrinsic solute removal
capacity and to the higher residual renal function. Under
steady state conditions, SRI can be different not only
because of the treatment schedule, but also due to a
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variable efficiency in different moments of the week. This
makes the static view of SRI less appealing compared to a
dynamic view of the same index. The advantages of SRI
over Kt/V are in fact more evident when the dialysis
prescription in a given patient is changed and measure-
ments are made during a transient state, before a new
steady state is achieved. In children, the assumption that
urea removal is equal to urea generation has been shown to
be imprecise. The further concept that urea generation is
proportional to dietary protein intake has also been shown
to be incorrect. Pediatric patients display a variable degree
of anabolism, and in our population PCR was never
comparable to DPI. The variable protein intake combined
with the variable state of urea metabolism in children
means that the dialysis requirement is continuously chang-
ing and the treatment schedules need to be frequently
modified. Under these circumstances, as urea generation
rate exceeds removal or clearance values are too low, the
excess urea accumulates in the patient’s body, causing the
BUN to rise. As the BUN rises, the gradient for removal
across the dialysis membrane increases so that removal also
increases. In this situation, removal and body content
change proportionally while the SRI remains unchanged.
Similarly, if the treatment schedule of a patient changes
and the patient is moved from a CAPD regimen to HD, the
Kt/V is suddenly increased, but solute removal in relation
to body content is still maintained and the SRI does not
change. This is due to the exponential decrease in BUN
during high efficiency HD where the same removal of
solute, compared to CAPD, can only be achieved if a higher
peak BUN is reached before the dialysis session.
In conclusion, clearance may not be a good method to
compare treatments with different schedules and efficien-
cies. Despite the attempt to normalize the achieved liters of
clearance by the liters of total body water, the derived Kt/V
index is not an adequate parameter to assess treatment
adequacy on a unified basis, and a different scaling is always
needed. These differences are even more evident in chil-
dren, where the urea distribution space accessed by the
intermittent treatments is never equal to total body water,
as demonstrated by significant postdialytic rebounds [15,
16].
Therefore, we suggest the practical utilization of the SRI
as a unified basis to compare disparate therapies. Accord-
ing to our prospective study, weekly SRI including residual
renal function should always be greater than 1.7. Since
extracorporeal hemodialysis may be less efficient in chil-
dren than CAPD or ANPD because of its intermittent
nature and the high relative efficiency compared to the
solute transfer velocity between compartments in the body,
children on hemodialysis should be carefully monitored
when residual renal function decreases. In some cases they
should be moved to other treatments with a daily or
continuous schedule, which in these patients may provide a
more adequate therapy and renal replacement.
Therefore, we suggest that Kt/V can be used as a marker
of treatment efficiency for small molecules, but an ade-
quate adjustment of the reference scale must be made for
each treatment. The SRI can be an alternative tool or an
additional tool for the assessment of treatment adequacy.
SRI appears to be a more reliable index of adequacy
compared to Kt/V. Thus, at least an integration between
the two treatments is strongly recommended.
Nevertheless, since adequacy is a wider concept that
should include other solutes as a control, we emphasize
that SRI can be used for different solutes utilizing the same
scaling system. Correction of acid-base disorders, electro-
lyte homeostasis and maintenance of dry body wt and blood
pressure control will help in defining the overall concept of
dialysis adequacy.
What is the best index for adequacy in children?
In our study we analyzed a population of CAPD patients
who were well rehabilitated and therefore, by assumption,
adequately treated.
Weekly Kt/V for urea was 1.78. Can we consider the
Kt/V index a good parameter for describing CAPD effi-
ciency and adequacy? To a certain extent we accept this
index, even though some adjustments have to be done to
the scale. Equal scales, however, cannot be used for
different treatments. It is evident that clearance (K) per se
does not represent the real efficiency of the treatment,
while it only describes the instantaneous ratio between the
solute removal and its concentration in the blood entering
the system. Only when the clearance value is multiplied by
the time in which that clearance is applied to the patient,
will the result obtained offer a reliable measure of the
clinical clearance. Therefore, while instantaneous clear-
ance, K (5 to 10 ml/min in CAPD, 200 to 300 ml/min in
HD), represents the efficiency of the dialytic system in a
given moment, the product Kt gives the number of liters of
blood cleared by the dialytic treatment in a given period.
Finally, if we normalize this product by the volume of
distribution of the studied solute in the body, we will
achieve a fractional clearance value that represents the
ratio between the number of liters of clearance obtained
and the number of liters that should be cleared in the body
(Kt/V).
We could also consider the overall amount of urea
removed from the body by the treatment. However, to
make two different treatments comparable, this parameter
must assume identical volumes of distribution for the
solute, similar predialysis blood levels and similar rates of
ultrafiltration. Since clearance can also be considered as
the ratio between solute removal over time, and the solute
concentration in blood (plasma for the solutes confined to
the extracellular fluid) the rate of removal can therefore be
identified by the formula,
R ~mg/min! 5 K ~ml/min! 3 P ~mg/ml!
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While in CAPD clearance and removal are proportional
and linearly correlated since the solute concentration in
blood is constant, in hemodialysis and other forms of
intermittent peritoneal dialysis this may not be the case,
since the solute concentration in blood declines exponen-
tially during treatment. Therefore, in hemodialysis, the
removal rate is maximal at the beginning of the treatment
while it is much lower at the end of the session. In such a
condition the efficiency of the system characterizes the
profile of concentration of the solute in blood during
treatment, and the solute concentration at the end of the
session will be governed by the formula
Ct 5 Co 3 e(2Kt/V)
where Ct is the final concentration of the solute in blood
after dialysis, Co is the concentration at the beginning and
Kt/V is the exponential term representing the fractional
clearance. However, while identical Kt products lead to
equal amounts of liters of clearance in the patient, they do
not necessarily lead to identical amounts of solute removal
in different treatments. The decline in concentration of the
solute in blood may be different according to the different
efficiencies of the system. Similar Kt products may produce
different amounts of solute removal or, different Kt prod-
ucts may lead to similar amounts of solute removal. For
example, as the time is reduced, the solute mass transfer
between body compartments may be too low to permit a
complete equilibration. Therefore, when time is short and
clearance is high, the treatment may not have access to the
real volume of distribution of the solute and an apparently
smaller volume is cleared. In such condition a sudden
decrease in blood concentration is observed after short
time from the beginning of the session and despite the high
clearance, the treatment will only remove small amounts of
solute. In such conditions a remarkable rebound in solute
concentration after the treatment will be observed, suggest-
ing that some districts of the body are not cleared at all, and
an important disequilibrium between compartments oc-
curs. This may partially explain why intermittent treatments
like hemodialysis may require a higher Kt/V to achieve the
same amount of solute removal and the same degree of
patient well being. It becomes clear that time (t) may be a
critical factor in evaluating the efficiency of a given treat-
ment, and intermittent treatments can hardly be compared
with continuous treatments using the same parameter and
the same scale.
In peritoneal dialysis the possibility of manipulating the
technique to modify treatment efficiency is limited in
comparison with hemodialysis. One of the most critical
factors in the overall efficiency of the system is the perme-
ability of the peritoneal membrane. The evaluation of the
dialysate/plasma equilibration curves for glucose, urea and
creatinine permits a definition of the better technique for
an effective peritoneal dialysis treatment [17]. In a typical
four hour exchange, the value of equilibration for urea is
near 1, so that the clearance value approaches the volume
of drainage divided by the duration of the exchange.
In children, considering a daily regimen of four ex-
changes and a variable ultrafiltration between 0.5 and 1
liter/day, weekly clearances for urea between 28 and 32
liters can be reached in CAPD. The equilibration test also
permit a definition of the better strategy to obtain the
maximal ultrafiltration in relation to the high, low or
normal permeability of the membrane [18]. In such condi-
tions, the dialysis prescription can be made once the
peritoneal permeability of the patient has been defined.
CAPD or other forms of peritoneal dialysis such as high
volumes CAPD, tidal PD, continuous cycling PD, intermit-
tent PD or ANPD can be prescribed to achieve the desired
level of efficiency.
In our study we compared the ANPD and HD techniques
with CAPD. While ANPD permitted satisfactory results to
be achieved, hemodialysis displayed a limited efficiency
that was only corrected by the residual renal function. The
explanation of this observation is in the intermittent nature
of HD. In fact, in HD the instantaneous clearance is much
higher than in CAPD but it is applied for a shorter period
of time compared to CAPD, and it is applied to a blood
concentration profile that declines rapidly during treat-
ment. In such conditions the amount of solute removal
derived from the product (K 3 P) becomes lower, the
solute concentration in blood increases progressively be-
tween dialysis sessions, and the degree of uremic intoxica-
tion and catabolism becomes greater. The adequate
amount of solute removal can only be obtained in these
circumstances if the pre-dialysis BUN reaches very high
concentrations (peak concentration).
In ANPD the instantaneous clearance is lower than in
HD; however, in this technique the daily regimen permits
the blood concentration profiles to be more stable and the
product (K 3 P) leads to a sufficient amount of solute
removal. For this reason, when an intermittent form of
peritoneal dialysis is indicated due to the peritoneal mem-
brane characteristics or social needs, an adequate number
of liters of solution as well as an adequate treatment time
should be prescribed according to the overall capacity of
solute removal more than to the Kt/V. Nevertheless, if Kt/V
is the index used, an appropriate adjustment of the scale for
each technique is strongly recommended. Under these
circumstances the SRI may become the appropriate tool, or
at least it becomes a useful parameter to be integrated with
Kt/V for a correct assessment of treatment adequacy. In
our population we also studied the possibility of normaliz-
ing the product Kt by the patient surface area instead of
volume (Table 2). The derived index (Kt/SA) is expressed
in liters of clearance per week/m2 and may represent a
further approach to compare disparate therapies. Again,
the intermittent nature of hemodialysis makes clearance a
parameter that must be adjusted adequately when com-
pared with daily or continuous therapies [19].
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In conclusion, a certain amount of solute removal per
week is the real target of the treatment. Different Kt
products may lead to the same amount of solute removal
because of the different kinetics of the solute concentration
in the blood and body compartments. At the same time,
similar Kt products do not always lead to the same amount
of solute removal, and the factor of “time” becomes the
critical point for the adequacy of treatment. In hemodial-
ysis and other forms of intermittent peritoneal dialysis
treatment, clearance and Kt/V may therefore be fallacious
parameters to identify an adequate prescription, since the
amount of solute removed will depend on the time that the
clearance is applied, on the blood concentration profile
during treatment, on the mass transfer rate between body
compartments, and on the average blood concentration to
which the clearance is applied. On the contrary, clearance
can be safely used in CAPD for the dialysis prescription
since it perfectly correlates with the amount of solute
removal at a given stable concentration of the solute in
blood. Even though the Kt/V only represents the adequacy
parameter for urea, this index may be sufficiently precise to
define at least the adequacy of blood purification from this
solute.
Reprint requests to Dr. Claudio Ronco, Department of Nephrology, St.
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APPENDIX
Abbreviations used in this article are: ANPD, automatic nightly perito-
neal dialysis; BUN, blood urea nitrogen; CAPD, continuous ambulatory
peritoneal dialysis; DPI, daily protein intake; HD, hemodialysis; Kt/V,
ratio of the number of liters of clearance cleared by dialysis treatment
during a given time; nonUNex, daily excretion of urea and non-urea
nitrogen; PCR, protein catabolic rate; PNA, protein equivalent of urea
nitrogen appearance rate; SRI, Solute Removal Index; TAC, time aver-
aged concentrations; UNex, daily excretion of urea and nitrogen.
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